Swiss Life: Wrapper Entities, Ratings and Regulatory Record

Swiss Life is among the largest life insurers in Europe and one of the most established names in the insurance wrapper market. It is also a carrier where the gap between the group brand and the contracting entity matters more than usual, and where the public record contains material that any adviser running diligence needs to have read.

Which entity actually issues the policy

The wrapper business sits in the Global Private Wealth division of Swiss Life Global Solutions. Swiss Life does not use the term “private placement life insurance” in its own current marketing, describing instead “high-end life insurance solutions for sustainable wealth planning”.

• Swiss Life (Luxembourg) S.A. — incorporated 1985, Luxembourg. Regulator: Commissariat aux Assurances. The principal wrapper issuer, and roughly six times the size of the Liechtenstein company.
• Swiss Life (Liechtenstein) AG — Ruggell, Liechtenstein. Regulator: Financial Market Authority Liechtenstein. Subject to a portfolio transfer — see below.
• Swiss Life (Singapore) Pte. Ltd. — MAS-licensed Direct Insurer (Life), serving Asian clients.
• Swiss Life Ltd (Swiss Life AG) — the Swiss domestic insurer and the group’s rated entity. We found no evidence that it issues cross-border wrapper business.

Named products include the Life Asset Portfolio in country-specific versions and, at the top of the range, Swiss Life Generations. Asia is served by a separate range including Alpha, Gemstone, Zenith and Infinity.

The rating question, stated precisely

Swiss Life’s own investor disclosure states that on 12 August 2026, S&P Global Ratings confirmed an Insurer Financial Strength Rating of A+, stable outlook, for Swiss Life Ltd (verified against both the English and German editions of that page on 19 August 2026). Swiss Life Holding Ltd carries an issuer credit rating of A-. S&P appears to be the group’s sole rating agency; we found no A.M. Best, Moody’s or Fitch rating.

That A+ does not extend to the wrapper-issuing subsidiaries. The Solvency and Financial Condition Reports for Swiss Life (Luxembourg) S.A. and Swiss Life (Liechtenstein) AG disclose no ratings, and neither appears on the group ratings page. Swiss Life (Singapore) is likewise unrated on its public disclosure page.

This is not a criticism of Swiss Life — it is normal in this market, and it is the general position across wrapper subsidiaries. But it is routinely misrepresented in third-party comparisons, and it matters: a policyholder’s contractual claim lies against the issuing subsidiary. Where a group rating is cited in a proposal, the correct diligence question is whether there is a formal parental guarantee, and if so, in what terms.

Financial scale

Group, year ended 31 December 2025: third-party assets under management CHF 145.707 billion; total equity CHF 7,478 million; net profit CHF 1,256 million; gross written premiums CHF 20,871 million. The Swiss Solvency Test ratio was 213%, against a strategic ambition range of 140–190%.

Swiss Life (Luxembourg) S.A., year ended 31 December 2024: Solvency II SCR coverage 161%; eligible own funds EUR 366.5 million; total assets EUR 16,545.5 million, of which EUR 14,501.7 million unit-linked. A 2025 report had not been published at the time of writing.

Swiss Life (Liechtenstein) AG, year ended 31 December 2025: SCR coverage 164%; eligible own funds CHF 40.9 million; total assets CHF 2,662.9 million, of which CHF 2,027.9 million unit-linked.

Note the asymmetry between a 213% group SST ratio and subsidiary Solvency II ratios in the 160s. These are different regimes measured on different bases and are not comparable — but the issuing entities are materially thinner than the group headline suggests, and it is the issuing entity that matters.

A structural change in progress: Liechtenstein

On 16 June 2026 the Austrian Financial Market Authority published a notice that Swiss Life (Liechtenstein) AG is transferring its entire insurance portfolio to Elips Life AG by way of merger. Both companies are registered at the same Ruggell address; elipsLife was acquired by Swiss Life International from Swiss Re. Swiss Life’s own Liechtenstein location page now names Elips Life AG as the operating entity.

The Liechtenstein company’s 2025 solvency report, published in April 2026, does not mention the merger; the regulator’s notice post-dates it. Anyone placing or reviewing a Liechtenstein Swiss Life contract should confirm the current issuing entity directly in writing. We could not verify the effective date, completion status, or whether Global Private Wealth business is included in the transferred portfolio.

Policyholder protection

For the Luxembourg company, the applicable regime is the one described in our Triangle of Security analysis. Swiss Life’s own explainer, published April 2025, describes the three parties — insurer, custodian bank and the Commissariat aux Assurances — and states that assets backing policies are “kept separate from the insurance company’s own assets and those of the custodian bank”, with policyholders holding an “absolute privilege or ‘super privilege’”.

That is accurate as far as it goes. The qualification worth adding is that the privilege is a priority ranking in insolvency over a defined pool of assets, not a compensation scheme — Luxembourg has no equivalent of the UK FSCS — and investment risk remains entirely with the policyholder.

For Liechtenstein, assets covering technical provisions are entered in a register and form a special estate under the Insurance Supervision Act, reinforced by Article 275 of the Solvency II Directive under which insurance claims take absolute precedence over that pool. We were unable to retrieve the underlying statutory text directly and flag the mechanism as verified by cross-reference rather than from the primary article.

Investment flexibility, minimums and costs

Premium may be allocated to discretionary or self-managed internal funds, dedicated funds in Luxembourg, an investment portfolio in Liechtenstein, or external funds from an insurer-approved list. For Swiss Life Generations the client proposes the custodian bank and asset manager, subject to insurer approval — the standard open-architecture arrangement.

Flexibility in Luxembourg is set by the regulator, not the carrier: CAA Circular Letter 26/1, effective 1 February 2026, defines investor categories from Type A (€125,000 premium, €250,000 securities wealth) to Type D (€1,000,000 and €2,500,000), with permitted asset classes widening at each step. These rules apply identically to every Luxembourg carrier.

Published minimums — treat with care. Swiss Life Generations states a minimum initial premium of EUR 1,000,000 with additional contributions from EUR 50,000. Life Asset Portfolio Key Information Documents state EUR 250,000. Those KIDs are dated 1 January 2018 and may be stale; there is no published group-wide minimum, and Asian product minimums are not disclosed.

Published costs come from the same 2018 PRIIPs documents and are stated as maxima: entry costs up to 0.21%, portfolio transaction costs up to 1.27%, other ongoing costs up to 2.12%, an annual administration fee up to 2.00% of contract value, and a switch fee of 1%. Reduction in yield over ten years is quoted at 2.87%–3.57% a year. These are wide ranges on a packaged European contract and should not be read as the cost of a large negotiated case, which is not disclosed. Our costs and economics analysis sets out how to compare on a like-for-like basis.

Regulatory record: the 2021 US deferred prosecution agreement

On 14 May 2021 the US Department of Justice announced a deferred prosecution agreement with Swiss Life Holding AG, Swiss Life (Liechtenstein) AG, Swiss Life (Singapore) Pte. Ltd. and Swiss Life (Luxembourg) S.A. — the holding company and all three wrapper-writing subsidiaries.

The companies admitted conspiring with US taxpayers to conceal more than $1.452 billion in assets and income from the Internal Revenue Service through approximately 1,608 insurance wrapper policies, over a conduct period running from 2005 to 2014. Total payment was $77,374,337, comprising $16,345,454 restitution, $35,782,375 forfeiture of gross fees and $25,246,508 in penalties. The agreement ran for three years and required cooperation with further investigations, disclosure under the DOJ Swiss Bank Program, outreach to current and former US clients on tax compliance, and remedial controls.

Three points of context, all of which matter. The conduct is more than a decade old and pre-dates the current compliance environment. The agreement was a deferred prosecution, not a conviction, and its three-year term would have expired around May 2024 — though we could not locate a source confirming formal dismissal. And the remediation obligations were substantial and supervised.

Set against that: the conduct concerned precisely the product line under discussion here, and precisely the client type. It is directly relevant to a US-connected family evaluating a wrapper, and it is the single most important reason such a family should obtain written confirmation of a carrier’s current US-person policy rather than relying on a brochure.

Beyond the DPA we found no enforcement proceedings by FINMA, the CAA, the Liechtenstein FMA or MAS against any Swiss Life entity, and no material legal proceedings disclosed in the 2025 annual report. Several regulator registers could not be fully searched, so this is not an exhaustive negative.

US taxpayers

On the published evidence, Swiss Life should be treated as a non-US carrier that does not write US-compliant PPLI. Every published market list excludes the United States; we found no election under IRC § 953(d) for any Swiss Life entity; and Swiss Life is not among the seven carriers the US Senate Finance Committee identified in February 2024 as the largest providers of PPLI to US clients.

We record this as a reasoned inference rather than a verified fact: Swiss Life publishes no explicit US-person exclusion that we could locate, and a negative cannot be proved from public sources. Given the 2021 agreement specifically concerned US taxpayers, any US-connected engagement warrants direct written confirmation.

Frequently Asked Questions

Is Swiss Life rated A+?

Swiss Life Ltd, the Swiss insurer, holds an S&P Insurer Financial Strength Rating of A+ with a stable outlook, confirmed on 12 August 2026 per Swiss Life’s investor relations disclosure. The Luxembourg, Liechtenstein and Singapore subsidiaries that issue wrapper policies are unrated. A policyholder’s claim is against the issuing entity.

Does Swiss Life offer PPLI to US taxpayers?

There is no published evidence that it does. No US market page, no §953(d) election located, and Swiss Life is not among the seven carriers the Senate Finance Committee named as the largest US PPLI providers. Confirm directly before assuming either way.

What is the minimum premium?

There is no published group-wide minimum. Swiss Life Generations states EUR 1,000,000; Life Asset Portfolio Key Information Documents state EUR 250,000, but those documents date from January 2018 and may not reflect current terms.

What is happening in Liechtenstein?

The Austrian regulator published a notice in June 2026 that Swiss Life (Liechtenstein) AG is transferring its entire portfolio to Elips Life AG by merger. The effective date and the treatment of private wealth business could not be verified. Confirm the issuing entity in writing before proceeding.

---

Last reviewed 19 August 2026, from Swiss Life group and subsidiary disclosures, Solvency and Financial Condition Reports, regulator registers and publications of the US Department of Justice. PPLI.com is independent: we do not sell insurance, represent any carrier, or receive commission from any provider named here. Educational only; not legal, tax or insurance advice. Request a confidential consultation.